Mochida stock, pharmaceuticals

Mochida stock reports JPY 31.7 billion quarterly revenue

Published on 10/05/2026 at 14:53 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Mochida stock traded at JPY 3,090 on October 5, 2026, with a JPY 2,929 to JPY 3,965 yearly range. Q1 net income reached JPY 3.178 billion.

Mochida stock,  pharmaceuticals,  quarterly earnings,  revenue growth,  Tokyo Stock Exchange, Illustration mit AI erstellt.
Mochida stock, pharmaceuticals, quarterly earnings, revenue growth, Tokyo Stock Exchange, Illustration mit AI erstellt.

Mochida Pharmaceutical stock was last at JPY 3,090 on the Tokyo Stock Exchange on October 5, 2026, while its market capitalization stood at JPY 109.2 billion. The company reported Q1 FY2027 revenue of JPY 31.719 billion and net income of JPY 3.178 billion, giving the stock a clear earnings anchor.

Quarterly revenue rises 7.7 percent

According to Investing.com, Mochida's Q1 FY2027 revenue reached JPY 31.719 billion, compared with JPY 29.464 billion in the previous quarter. That represents a 7.7 percent increase and places quarterly sales above the JPY 30 billion mark.

The earnings comparison was stronger than the revenue comparison. Q1 net income of JPY 3.178 billion was more than double the JPY 1.561 billion recorded in the previous quarter, while basic earnings per share came to JPY 89.75.

Earnings date sets the next checkpoint

TradingView lists October 30, 2026, as Mochida's next earnings date. The next report will show whether the Q1 revenue increase develops into a broader fiscal-year trend or remains concentrated in the opening quarter.

The balance sheet gives the quarterly result additional context. Mochida held total assets of JPY 181.422 billion at June 30, 2026, compared with JPY 182.720 billion at March 31, 2026, while total equity stood at JPY 140.293 billion.

Stock holds inside yearly range

Mochida stock was last at JPY 3,090 on October 5, 2026, unchanged on the session. The JPY 2,929 to JPY 3,965 52-week range places the price JPY 875 below the yearly high and JPY 161 above the yearly low.

For investors, the central issue is the relationship between the latest earnings improvement and the October reporting date. Revenue growth of 7.7 percent, a more than doubling of quarterly net income and the JPY 3,090 share price provide three concrete markers for that assessment.

Mochida stock facts

  • Company: Mochida Pharmaceutical Co., Ltd.
  • Ticker: 4534
  • Trading venue: Tokyo Stock Exchange
  • Price (as of October 5, 2026, 3:30 p.m. JST): JPY 3,090
  • Market capitalization: JPY 109.2 billion (as of October 5, 2026)
  • 52-week range: JPY 2,929-JPY 3,965 (as of October 5, 2026)
  • Sector / Industry: Health Care / Pharmaceuticals

Upcoming dates for Mochida stock

  • October 30, 2026: Next earnings report

Disclaimer...

en | boerse | 70233350 |